Prosecution Insights
Last updated: May 29, 2026
Application No. 17/456,022

POLYETHER POLYCARBONATE DIOL AND METHOD FOR PRODUCING THE SAME

Final Rejection §103
Filed
Nov 22, 2021
Priority
Aug 07, 2019 — JP 2019-145523 +1 more
Examiner
NERANGIS, VICKEY M
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mitsubishi Chemical Corporation
OA Round
6 (Final)
56%
Grant Probability
Moderate
7-8
OA Rounds
0m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
654 granted / 1161 resolved
-8.7% vs TC avg
Strong +29% interview lift
Without
With
+28.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
51 currently pending
Career history
1222
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
81.1%
+41.1% vs TC avg
§102
5.3%
-34.7% vs TC avg
§112
3.3%
-36.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1161 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment All outstanding rejections, except for those maintained below, are withdrawn in light of applicant’s amendment filed on 3/2/2026. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior office action. The new grounds of rejection set forth below are necessitated by applicant’s amendment filed on 3/2/2026. In particular, claim 1 has been amended to add a transesterification catalyst in an amount of 10-1500 µmol per mol of polytetramethylene ether glycol. Thus, the following action is properly made final. Claim Rejections - 35 USC § 103 Claims 1-16 are rejected under 35 U.S.C. 103 as being unpatentable over Bott (US 5,173,518) in view of Hioki (WO 2018/117219 A1, citations to US 11,608,405 as English-language equivalent). With respect to claims 1, 4, 6-10, 12-16, Bott discloses cellular (foam) polyurethane elastomers derived from polyisocyanate and a polyether polycarbonate diol which contains polyoxytetramethylene glycol radicals having a Mn of 50-500 (abstract), wherein the polyether polycarbonate diol is prepared from a polyoxytetramethylene glycol and a diphenyl or dialkyl carbonate having 1-4 carbon atoms which includes dimethyl carbonate (col. 2, lines 19-38). Example 1 is to preparing polyether polycarbonate diols with a polyoxytetramethylenediol having Mn of 232 and diethyl carbonate, wherein the polyether polycarbonate diols have Mn of 1970 and OH number of 57 (col. 11, lines 55-68). The hydroxyl value of the polyoxytetramethylenediol is calculated from equation mw = (56,000 x n)/hydroxyl value as 483 mg-KOH/g with n = 2 for difunctional. Bott fails to (i) explicitly disclose an amount of transesterification catalyst of 10-1500 µm per mol of PTMG or (ii) explicitly disclose a polyether polycarbonate having chain terminal groups other than hydroxy groups. With respect to (i), in Example 1, 12.5 g of tetraisopropyl orthotitanate (i.e., transesterification catalyst having molecular weight of 284 g/mol) per 7.54 mol of polyoxytetramethylenediol PTMG), which provides for an amount of transesterificatiaon catalyst in µmol per mol of PTMG of about 5,800 which is above claimed range of 10-1500. Even so, case law holds “applicant must look to the whole reference for what it teaches. Applicant cannot merely rely on the examples and argue that the reference did not teach others.” In re Courtright, 377 F.2d 647, 153 USPQ 735,739 (CCPA 1967). Bott teaches that a transesterification catalyst is added in an amount of 0.001-2 wt % (col. 5, lines 16-23). Given that the disclosure of Bott is not limited to the examples and further given that Bott teaches that a suitable amount of transesterification catalyst can be as low as 0.001 wt % (as compared to exemplified 0.5 wt %), it would have been obvious to one of ordinary skill in the art to utilize relatively lower amounts of transesterification catalyst which overlap with claimed range of 10-1500. With respect to (ii), Hioki discloses a polycarbonate polyol prepared from a polyhydric alcohol having a hydroxyl value of 20-450 mg KOH/g and a formula PNG media_image1.png 38 214 media_image1.png Greyscale , wherein m is 2-4 and RA1 represents a carbon chain having 2-5 carbon atoms (abstract; col. 3, lines 13-19). Hioki teaches that the polycarbonate polyol has mainly hydroxy groups as terminal end groups but when prepared from dialkyl or dialkyl carbonates such as dimethyl carbonate, alkoxy (i.e., methoxy) groups “may remain as a molecular chain terminal” in an amount of up to 5 wt % (col. 17, line 61 to col. 18, line 19). Given that both Bott and Hioki are drawn to polyether polycarbonate polyols derived from polyether glycols and dialkyl carbonates and further given that Hioki teaches that reacting hydroxyl groups in the presence of dialkyl carbonates results in an expected impurity of 5 wt % or less, it would have been obvious to one of ordinary skill in the art to prepare a polyether polycarbonate diol like claimed having alkoxy terminal groups from Hioki. With respect to claims 2 and 3, the terminal alkoxy group is derived from the diphenyl or dialkyl carbonate having 1-4 carbon atoms. A dialkyl group with 1 carbon atom provides for a terminal methoxy group, and a dialkyl group with 4 carbon atoms provides for a terminal butoxy group. With respect to claim 5, because the hydrolysis product is formed at the carbonate unit, the hydroxyl group value would be at least the hydroxy value for the polyoxytetramethylene glycol, e.g., 483 mg-KOH/g. With respect to claim 11, in Example 7.54 mol of polyoxytetramethylene diol is mixed with 6.59 mol of diethyl carbonate, i.e, 0.87 molar ratio. Response to Arguments Applicant's arguments filed 3/2/2026 have been fully considered but they are not persuasive. Specifically, applicant argues that the amount of transesterification catalyst of 10-1500 µmol per mole of PTMG provides unexpected results. Convincing secondary considerations such as unexpected results require data that is reasonably commensurate in scope with the claims rather than statements made in the specification. Case law holds that whether the unexpected results are the result of unexpectedly improved results or a property not taught by the prior art, the “objective evidence of nonobviousness must be commensurate in scope with the claims which the evidence is offered to support.” No criticality has been shown for the claimed range of 10-1500 or how it compares to exemplified amount of about 5,800 µmol per mole of PTMG. Case law holds that comparative showings must compare the claimed subject matter with the closest prior art to be effective. See In re Burckel, 592 F.2d 1175, 1179, 201 USPQ 67, 71 (CCPA 1979). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to VICKEY NERANGIS whose telephone number is (571)272-2701. The examiner can normally be reached 8:30 am - 5:00 pm EST, Monday - Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VICKEY NERANGIS/Primary Examiner, Art Unit 1763 vn
Read full office action

Prosecution Timeline

Show 8 earlier events
Jul 11, 2025
Response Filed
Aug 12, 2025
Final Rejection mailed — §103
Oct 27, 2025
Response after Non-Final Action
Nov 12, 2025
Request for Continued Examination
Nov 13, 2025
Response after Non-Final Action
Dec 16, 2025
Non-Final Rejection mailed — §103
Mar 02, 2026
Response Filed
Apr 01, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637567
STYRENE-BASED RESIN COMPOSITION
4y 5m to grant Granted May 26, 2026
Patent 12630736
NOVEL NANOEMULSIONS, METHODS OF THEIR PRODUCTION AND RELATED USES AND PRODUCTS
4y 7m to grant Granted May 19, 2026
Patent 12617945
THERMOPLASTIC COMPOSITION
5y 7m to grant Granted May 05, 2026
Patent 12617950
POLYMER PARTICLES COMPRISING LIGNIN AND RELATED ADDITIVE MANUFACTURING METHODS
4y 6m to grant Granted May 05, 2026
Patent 12606672
CURABLE COMPOSITION
3y 10m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
56%
Grant Probability
85%
With Interview (+28.9%)
3y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1161 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month